![Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle? Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?](https://pub.mdpi-res.com/medicina/medicina-58-00472/article_deploy/html/images/medicina-58-00472-g001.png?1648195407)
Medicina | Free Full-Text | Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
![MEDICINE METFORMIN ACTAVIS DIABETES MEDICINE Editorial Photography - Image of actavis, kastrup: 88254327 MEDICINE METFORMIN ACTAVIS DIABETES MEDICINE Editorial Photography - Image of actavis, kastrup: 88254327](https://thumbs.dreamstime.com/z/medicine-metformin-actavis-diabetes-medicine-kastrup-copenhagen-denmark-march-gm-medicne-disease-photo-francis-dean-88254327.jpg)
MEDICINE METFORMIN ACTAVIS DIABETES MEDICINE Editorial Photography - Image of actavis, kastrup: 88254327
Ozempic, las inyecciones que prometen acabar con la obesidad y que arrasan en el mercado negro | Salud y bienestar | EL PAÍS
![Hasta un 40% de los ingresos de personas con diabetes en Medicina Interna es a causa de una enfermedad cardiovascular Hasta un 40% de los ingresos de personas con diabetes en Medicina Interna es a causa de una enfermedad cardiovascular](https://img.europapress.es/fotoweb/fotonoticia_20201203102518_420.jpg)